As another major class of defensins in humans, low expression levels of HBD1, HBD2 and HBD3 had been reported in colon cancer [207, 270] and OSCC [271, 272], while one study showed increased expression of HBD2 in OSCC [273]. This evidence concerns the gene DEFB1 and malignant colon neoplasm.